Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | FABP5 | Q01469 | 2/20 | 0.35 |
| ▸ | CASP3 | P42574 | 1/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
| ▸ | FABP7 | O15540 | 1/20 | 0.33 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31369929 | 0.91 | EPHX2 (0.39) | EPHX2KMT2AFABP5CASP3PTPN1 | |
| SCHEMBL25177525 | 0.82 | PTGIR (0.39) | EPHX2KMT2AFABP5FABP7 | |
| SCHEMBL29634050 | 0.82 | PTGIR (0.39) | EPHX2KMT2AFABP5FABP7 | |
| SCHEMBL25179555 | 0.82 | PTGIR (0.39) | EPHX2KMT2AFABP5FABP7 | |
| SCHEMBL29855056 | 0.82 | PTGIR (0.39) | EPHX2KMT2AFABP5FABP7 | |
| SCHEMBL25178688 | 0.82 | PTGIR (0.37) | EPHX2KMT2AFABP5CASP3FABP7 | |
| SCHEMBL25179560 | 0.82 | PTGIR (0.37) | EPHX2KMT2AFABP5CASP3FABP7 | |
| SCHEMBL29633721 | 0.82 | PTGIR (0.37) | EPHX2KMT2AFABP5CASP3FABP7 | |
| SCHEMBL29855063 | 0.82 | PTGIR (0.37) | EPHX2KMT2AFABP5CASP3FABP7 | |
| SCHEMBL25657532 | 0.81 | PTGIR (0.35) | EPHX2KMT2AFABP5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260015313-A1 | AMINO ACID ACTIVE ESTER AND SALT THEREOF | PEPTIDREAM INC (JP) | 2026-01-15 | — | — | US | disclosed |
| EP-4534524-A1 | AMINO ACID ACTIVE ESTER AND SALT THEREOF | PeptiDream Inc. (JP) | 2025-04-09 | — | — | EP | disclosed |
| WO-2023234425-A1 | AMINO ACID ACTIVE ESTER AND SALT THEREOF | ペプチドリーム株式会社 | 2023-12-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260015313-A1 | AMINO ACID ACTIVE ESTER AND SALT THEREOF | NSUN3, BCAT1, SLC43A1 | EPHX2 4031/4885KMT2A 1052/4885FABP5 3374/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.